NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|149024222|gb|EDL80719|]
View 

exostoses (multiple)-like 1 (predicted) [Rattus norvegicus]

Protein Classification

exostosin( domain architecture ID 10503393)

exostosin is a family 47 glycosyltransferase that is required for the biosynthesis of heparan-sulfate

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
Glyco_transf_64 pfam09258
Glycosyl transferase family 64 domain; Members of this family catalyze the transfer reaction ...
413-649 8.41e-120

Glycosyl transferase family 64 domain; Members of this family catalyze the transfer reaction of N-acetylglucosamine and N-acetylgalactosamine from the respective UDP-sugars to the non-reducing end of [glucuronic acid]beta 1-3[galactose]beta 1-O-naphthalenemethanol, an acceptor substrate analog of the natural common linker of various glycosylaminoglycans. They are also required for the biosynthesis of heparan-sulphate.


:

Pssm-ID: 430488  Cd Length: 241  Bit Score: 356.99  E-value: 8.41e-120
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 149024222  413 FSAVIWVGVSEESPP-KLIQEVAGSRHCAQILILWNSEKPPPD--RWPKTAVPLTVIEGHRKV-SDRFFLYSNISTNVIL 488
Cdd:pfam09258   1 FTAVINTYYSRIDLLlKLLQRYAGSPHLAKIIVLWNNPKPPPElsRWPGTGVPVTVIRQKRNSlNNRFLPYPEIETDAVL 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 149024222  489 SLDAQSTLSTSEVDFAFVVWQSFPERMVGFVTWSHFWDEARQGWGYSAEMANEFSMVLTTAAFYHRYYHTLFTHSLPKAL 568
Cdd:pfam09258  81 SLDDDILLSTDEIDFAFRVWRSFPDRIVGFPPRSHFWDLSSGRWGYTSEWTNEYSMVLTGAAFYHRYYLYLYTHSLPKSL 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 149024222  569 RSIADETPTCVDILMNFLVATVTKLPPIKVPYSRQHQEAAPMASEGPRPVPEPQALDQDCINRLAAGLGHMPLVSSRVRL 648
Cdd:pfam09258 161 RTLVDETQNCEDILMNFLVANVTRKPPVKVTQRKQFKEGKNSGKVGLSSRPGHFLQRSKCINKFAAVFGYMPLVYSQIRL 240

                  .
gi 149024222  649 D 649
Cdd:pfam09258 241 D 241
Exostosin pfam03016
Exostosin family; The EXT family is a family of tumour suppressor genes. Mutations of EXT1 on ...
108-329 1.54e-43

Exostosin family; The EXT family is a family of tumour suppressor genes. Mutations of EXT1 on 8q24.1, EXT2 on 11p11-13, and EXT3 on 19p have been associated with the autosomal dominant disorder known as hereditary multiple exostoses (HME). This is the most common known skeletal dysplasia. The chromosomal locations of other EXT genes suggest association with other forms of neoplasia. EXT1 and EXT2 have both been shown to encode a heparan sulphate polymerase with both D-glucuronyl (GlcA) and N-acetyl-D-glucosaminoglycan (GlcNAC) transferase activities. The nature of the defect in heparan sulphate biosynthesis in HME is unclear.


:

Pssm-ID: 397245  Cd Length: 290  Bit Score: 158.36  E-value: 1.54e-43
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 149024222  108 AQRRILDSLEGSR--YYALSPAEACLLlFLPS-------------------QDRRGACGPLPPNWN--GGRNHLVLSLYP 164
Cdd:pfam03016  33 AEQFLLESILHSRieCRTSDPDEADCF-FVPFyasldasrhllnsaltdlfRELLDWLKSQYPYWNrsGGRDHFIVSGHP 111
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 149024222  165 APCTRL-------GQAMVA--EASPSLDIFRPGFDVALPYLPEAHPlkggAPGSLQRHGPQPGATLVAVAEErGRWRITT 235
Cdd:pfam03016 112 AWSFRRtapdvdwGRAMLLnlTVLFSEDQFRPGKDVALPYPTPFHP----DIGQWQDISPSNRRKTLLFFAG-NRRRGYS 186
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 149024222  236 THASACPWD-----RNCEQDPGPQQTY----PGEILPNVTFCLIPGHRSATSC-FLQALQAGCIPVLLSPRWELPFSEVI 305
Cdd:pfam03016 187 GKIRPLLLEeckgnPDADICGGLQCTPgrdkYMELLRSSRFCLQPPGDTPTSPrLFDALLAGCIPVIISDGWELPFADVI 266
                         250       260
                  ....*....|....*....|....
gi 149024222  306 DWTKAAIVADERLPLQVLAALREM 329
Cdd:pfam03016 267 DWRKFSVFVPENDIPELKSILRSL 290
 
Name Accession Description Interval E-value
Glyco_transf_64 pfam09258
Glycosyl transferase family 64 domain; Members of this family catalyze the transfer reaction ...
413-649 8.41e-120

Glycosyl transferase family 64 domain; Members of this family catalyze the transfer reaction of N-acetylglucosamine and N-acetylgalactosamine from the respective UDP-sugars to the non-reducing end of [glucuronic acid]beta 1-3[galactose]beta 1-O-naphthalenemethanol, an acceptor substrate analog of the natural common linker of various glycosylaminoglycans. They are also required for the biosynthesis of heparan-sulphate.


Pssm-ID: 430488  Cd Length: 241  Bit Score: 356.99  E-value: 8.41e-120
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 149024222  413 FSAVIWVGVSEESPP-KLIQEVAGSRHCAQILILWNSEKPPPD--RWPKTAVPLTVIEGHRKV-SDRFFLYSNISTNVIL 488
Cdd:pfam09258   1 FTAVINTYYSRIDLLlKLLQRYAGSPHLAKIIVLWNNPKPPPElsRWPGTGVPVTVIRQKRNSlNNRFLPYPEIETDAVL 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 149024222  489 SLDAQSTLSTSEVDFAFVVWQSFPERMVGFVTWSHFWDEARQGWGYSAEMANEFSMVLTTAAFYHRYYHTLFTHSLPKAL 568
Cdd:pfam09258  81 SLDDDILLSTDEIDFAFRVWRSFPDRIVGFPPRSHFWDLSSGRWGYTSEWTNEYSMVLTGAAFYHRYYLYLYTHSLPKSL 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 149024222  569 RSIADETPTCVDILMNFLVATVTKLPPIKVPYSRQHQEAAPMASEGPRPVPEPQALDQDCINRLAAGLGHMPLVSSRVRL 648
Cdd:pfam09258 161 RTLVDETQNCEDILMNFLVANVTRKPPVKVTQRKQFKEGKNSGKVGLSSRPGHFLQRSKCINKFAAVFGYMPLVYSQIRL 240

                  .
gi 149024222  649 D 649
Cdd:pfam09258 241 D 241
Exostosin pfam03016
Exostosin family; The EXT family is a family of tumour suppressor genes. Mutations of EXT1 on ...
108-329 1.54e-43

Exostosin family; The EXT family is a family of tumour suppressor genes. Mutations of EXT1 on 8q24.1, EXT2 on 11p11-13, and EXT3 on 19p have been associated with the autosomal dominant disorder known as hereditary multiple exostoses (HME). This is the most common known skeletal dysplasia. The chromosomal locations of other EXT genes suggest association with other forms of neoplasia. EXT1 and EXT2 have both been shown to encode a heparan sulphate polymerase with both D-glucuronyl (GlcA) and N-acetyl-D-glucosaminoglycan (GlcNAC) transferase activities. The nature of the defect in heparan sulphate biosynthesis in HME is unclear.


Pssm-ID: 397245  Cd Length: 290  Bit Score: 158.36  E-value: 1.54e-43
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 149024222  108 AQRRILDSLEGSR--YYALSPAEACLLlFLPS-------------------QDRRGACGPLPPNWN--GGRNHLVLSLYP 164
Cdd:pfam03016  33 AEQFLLESILHSRieCRTSDPDEADCF-FVPFyasldasrhllnsaltdlfRELLDWLKSQYPYWNrsGGRDHFIVSGHP 111
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 149024222  165 APCTRL-------GQAMVA--EASPSLDIFRPGFDVALPYLPEAHPlkggAPGSLQRHGPQPGATLVAVAEErGRWRITT 235
Cdd:pfam03016 112 AWSFRRtapdvdwGRAMLLnlTVLFSEDQFRPGKDVALPYPTPFHP----DIGQWQDISPSNRRKTLLFFAG-NRRRGYS 186
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 149024222  236 THASACPWD-----RNCEQDPGPQQTY----PGEILPNVTFCLIPGHRSATSC-FLQALQAGCIPVLLSPRWELPFSEVI 305
Cdd:pfam03016 187 GKIRPLLLEeckgnPDADICGGLQCTPgrdkYMELLRSSRFCLQPPGDTPTSPrLFDALLAGCIPVIISDGWELPFADVI 266
                         250       260
                  ....*....|....*....|....
gi 149024222  306 DWTKAAIVADERLPLQVLAALREM 329
Cdd:pfam03016 267 DWRKFSVFVPENDIPELKSILRSL 290
 
Name Accession Description Interval E-value
Glyco_transf_64 pfam09258
Glycosyl transferase family 64 domain; Members of this family catalyze the transfer reaction ...
413-649 8.41e-120

Glycosyl transferase family 64 domain; Members of this family catalyze the transfer reaction of N-acetylglucosamine and N-acetylgalactosamine from the respective UDP-sugars to the non-reducing end of [glucuronic acid]beta 1-3[galactose]beta 1-O-naphthalenemethanol, an acceptor substrate analog of the natural common linker of various glycosylaminoglycans. They are also required for the biosynthesis of heparan-sulphate.


Pssm-ID: 430488  Cd Length: 241  Bit Score: 356.99  E-value: 8.41e-120
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 149024222  413 FSAVIWVGVSEESPP-KLIQEVAGSRHCAQILILWNSEKPPPD--RWPKTAVPLTVIEGHRKV-SDRFFLYSNISTNVIL 488
Cdd:pfam09258   1 FTAVINTYYSRIDLLlKLLQRYAGSPHLAKIIVLWNNPKPPPElsRWPGTGVPVTVIRQKRNSlNNRFLPYPEIETDAVL 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 149024222  489 SLDAQSTLSTSEVDFAFVVWQSFPERMVGFVTWSHFWDEARQGWGYSAEMANEFSMVLTTAAFYHRYYHTLFTHSLPKAL 568
Cdd:pfam09258  81 SLDDDILLSTDEIDFAFRVWRSFPDRIVGFPPRSHFWDLSSGRWGYTSEWTNEYSMVLTGAAFYHRYYLYLYTHSLPKSL 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 149024222  569 RSIADETPTCVDILMNFLVATVTKLPPIKVPYSRQHQEAAPMASEGPRPVPEPQALDQDCINRLAAGLGHMPLVSSRVRL 648
Cdd:pfam09258 161 RTLVDETQNCEDILMNFLVANVTRKPPVKVTQRKQFKEGKNSGKVGLSSRPGHFLQRSKCINKFAAVFGYMPLVYSQIRL 240

                  .
gi 149024222  649 D 649
Cdd:pfam09258 241 D 241
Exostosin pfam03016
Exostosin family; The EXT family is a family of tumour suppressor genes. Mutations of EXT1 on ...
108-329 1.54e-43

Exostosin family; The EXT family is a family of tumour suppressor genes. Mutations of EXT1 on 8q24.1, EXT2 on 11p11-13, and EXT3 on 19p have been associated with the autosomal dominant disorder known as hereditary multiple exostoses (HME). This is the most common known skeletal dysplasia. The chromosomal locations of other EXT genes suggest association with other forms of neoplasia. EXT1 and EXT2 have both been shown to encode a heparan sulphate polymerase with both D-glucuronyl (GlcA) and N-acetyl-D-glucosaminoglycan (GlcNAC) transferase activities. The nature of the defect in heparan sulphate biosynthesis in HME is unclear.


Pssm-ID: 397245  Cd Length: 290  Bit Score: 158.36  E-value: 1.54e-43
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 149024222  108 AQRRILDSLEGSR--YYALSPAEACLLlFLPS-------------------QDRRGACGPLPPNWN--GGRNHLVLSLYP 164
Cdd:pfam03016  33 AEQFLLESILHSRieCRTSDPDEADCF-FVPFyasldasrhllnsaltdlfRELLDWLKSQYPYWNrsGGRDHFIVSGHP 111
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 149024222  165 APCTRL-------GQAMVA--EASPSLDIFRPGFDVALPYLPEAHPlkggAPGSLQRHGPQPGATLVAVAEErGRWRITT 235
Cdd:pfam03016 112 AWSFRRtapdvdwGRAMLLnlTVLFSEDQFRPGKDVALPYPTPFHP----DIGQWQDISPSNRRKTLLFFAG-NRRRGYS 186
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 149024222  236 THASACPWD-----RNCEQDPGPQQTY----PGEILPNVTFCLIPGHRSATSC-FLQALQAGCIPVLLSPRWELPFSEVI 305
Cdd:pfam03016 187 GKIRPLLLEeckgnPDADICGGLQCTPgrdkYMELLRSSRFCLQPPGDTPTSPrLFDALLAGCIPVIISDGWELPFADVI 266
                         250       260
                  ....*....|....*....|....
gi 149024222  306 DWTKAAIVADERLPLQVLAALREM 329
Cdd:pfam03016 267 DWRKFSVFVPENDIPELKSILRSL 290
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH